Overview
Charles Connor is an Oncologist and an Internal Medicine provider in Plano, Texas. Dr. Connor has been practicing medicine for over 31 years and is rated as an Experienced provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Myelodysplastic Syndrome (MDS), Atypical Hemolytic Uremic Syndrome (aHUS), Pleuropulmonary Blastoma, and Lung Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
Accepted plan types not found. Please verify directly with the provider.
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3705 W. 15th Street, Street, Plano, TX 75075
Texas Oncology PA
Meera Shreedhara-Vasudha is an Oncologist and a Hematologist Oncology provider in Greenville, Texas. Dr. Shreedhara-Vasudha is rated as a Distinguished provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Her top areas of expertise are Leukocytosis, Paris-Trousseau Thrombocytopenia, RUNX1 Familial Platelet Disorder, and Paget Disease of the Breast. Dr. Shreedhara-Vasudha is currently accepting new patients.
Texas Oncology, P.A.
Andrew Paulson is an Oncologist and an Internal Medicine provider in Dallas, Texas. Dr. Paulson has been practicing medicine for over 17 years and is rated as a Distinguished provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Neuroendocrine Tumor, Pancreatic Cancer, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), Gastrostomy, and Endoscopy.
Udit Verma is a Hematologist Oncology specialist and an Oncologist in Dallas, Texas. Dr. Verma is rated as a Distinguished provider by MediFind in the treatment of Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). His top areas of expertise are Colorectal Cancer, Neuroendocrine Tumor, Familial Colorectal Cancer, and Pancreatic Cancer. Dr. Verma is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Atypical Hemolytic Uremic Syndrome (aHUS)
- Chronic B-Cell Leukemia (CBCL)Dr. Connor isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- Lung CancerDr. Connor isAdvanced. Learn about Lung Cancer.
- Multiple MyelomaDr. Connor isAdvanced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Connor isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Adult Soft Tissue SarcomaDr. Connor isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Connor isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Connor isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- B-Cell LymphomaDr. Connor isExperienced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Connor isExperienced. Learn about Breast Cancer.
- Breast Cancer in MenDr. Connor isExperienced. Learn about Breast Cancer in Men.